x
ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2015 > ESO - RUSSCO Session on Immune Checkpoint Blockage in Cancer Therapy
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

ESO - RUSSCO Session on Immune Checkpoint Blockage in Cancer Therapy

Not eligible for ESCO credits

18.11.2015

COURSES AND SEMINARS

Immunotherapy

Description

Chairs: Giuseppe Curigliano, IT- Dmitry Nosov, RU - David Zaridze, RU


The ESO–RUSSCO Session on Immune Checkpoint Blockage in Cancer Therapy will be held during XIX Russian Oncology Congress (17-19 November 2015).








Faculty list


FACULTY
E. Artamonova, RU
V. Breder, RU
G. Curigliano, IT
M. Maio, IT
D. Nosov, RU
R. Rosell, ES


Programme


18 November

   
14:10
 

The evolving role of immune checkpoint inhibitors in cancer treatment
E. Artamonova, RU  

14:30
 Questions
14:35 Biological markers of response to immune checkpoint inhibitors 
R. Rosell, ES
14:55 Questions
15:00  Non-small cell lung cancer (NSCLC): changing landscape of treatment and current issues
V. Breder, RU
15:20 Questions
15:25 Immune checkpoint Inhibitors for urologic cancer (RCC and bladder cancer)
D. Nosov, RU
15:45 Questions
15:50 Immune checkpoint-blockage induced toxicity
G. Curigliano, IT
 16:10 Questions
16:15 Checkpoint inhibitors: rational for combination strategy (vaccines, antiangiogenesis)
M. Maio, IT
16:35
 Questions